Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2496829 | 0.95 | TSHR (0.46) | TSHRMMP1MMP2MMP3MMP8 | |
| SCHEMBL2832316 | 0.93 | TSHR (0.49) | TSHRLMNATHRBFAAH | |
| SCHEMBL1323802 | 0.93 | TSHR (0.49) | TSHRLMNATHRBFAAH | |
| SCHEMBL6914196 | 0.93 | TSHR (0.49) | TSHRLMNATHRBFAAH | |
| Iodide SCHEMBL28802516 | 0.92 | TSHR (0.47) | TSHRLMNATHRBFAAH | |
| SCHEMBL516498 | 0.89 | TSHR (0.41) | TSHRALDH1A1THRB | |
| SCHEMBL27775650 | 0.85 | TSHR (0.42) | TSHRMMP1MMP2MMP3MMP8 | |
| Tetradecane SCHEMBL1083463 | 0.83 | TSHR (0.49) | TSHRLMNAALDH1A1THRBFAAH | |
| SCHEMBL14873 | 0.82 | TSHR (0.44) | TSHRALDH1A1THRB | |
| SCHEMBL11722092 | 0.82 | TSHR (0.39) | TSHRMMP1MMP2MMP3MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3872573-B1 | TONER ADDITIVE FORMULATION WITH CROSS-LINKED ORGANIC POLYMERIC ADDITIVE | XEROX CORP (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119775480-A | High-hardness self-cleaning antifouling resin and coating, and preparation method and application thereof | 广东省科学院化工研究所 | 2025-04-08 | — | — | CN | claimed |
| US-12252568-B2 | Silicone copolymer surface additive | XEROX CORPORATION (US) | 2025-03-18 | — | — | US | claimed |
| CN-115279422-B | pH responsive compositions, formulations, and methods of imaging tumors | 昂科纳诺医药公司 | 2024-03-29 | — | — | CN | claimed |
| CN-113376980-B | Titanium dioxide-free toner additive formulation with crosslinked organic polymer additive | 施乐公司 | 2023-12-05 | — | — | CN | claimed |
| US-11717471-B2 | Hydrogel microcapsules | ISP INVESTMENTS LLC (US) | 2023-08-08 | — | — | US | claimed |
| US-20230159683-A1 | Silicone Copolymer Surface Additive | XEROX CORPORATION | 2023-05-25 | — | — | US | claimed |
| US-20230025280-A1 | PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR | ONCONANO MEDICINE, INC. | 2023-01-26 | — | — | US | claimed |
| CN-115304757-A | Block type ink resin and preparation method thereof | 成都托展新材料股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-115279422-A | pH-responsive compositions, formulations, and methods of imaging tumors | 昂科纳诺医药公司 | 2022-11-01 | — | — | CN | claimed |
| US-7189341-B2 | Transition metal catalyst, an electroconductive material such as graphite; and a polymer binder blend of high molecular weight and low molecular weight acrylic (co)polymers, one having a higher glass transition temperature (Tg); catalytic inks for screen printing; use to make electrochemical sensors | ANIMAS TECHNOLOGIES, LLC (US) | 2007-03-13 | — | — | US | claimed |
| US-20060257775-A1 | Toner compositions with amino-containing polymers as surface additives | XEROX CORPORATION (US) | 2006-11-16 | — | — | US | claimed |
| US-5935750-A | A CARRIER COMPOSED OF A CORE AND A COATING OF A POLYMER CONTAINING QUTERNARY AMMONIUM SALT GROUP AND CONTAINS A CONDUCTIVE COMPONENT | XEROX CORPORATION (US) | 1999-08-10 | — | — | US | claimed |
| US-5115036-A | Ethylene-aminoalkyl (meth)acrylate copolymer; waste water treatment | SUMITOMO CHEMICAL CO., LTD. (JP) | 1992-05-19 | — | — | US | claimed |
| US-5069754-A | Reinforcement with amphoteric polymer | MITSUI-CYANAMID, LTD. (JP) | 1991-12-03 | — | — | US | claimed |
| US-5064879-A | METHOD FOR SORBING METALLIC IONS USING ETHYLENE-N,N-DIALKYL AMINOALKYL ACRYLATES POLYMERS | SUMITOMO CHEMICAL CO., LTD. (JP) | 1991-11-12 | — | — | US | claimed |
| US-5047287-A | Acrylonitrile-isoprene or butadiene/1,3-/ copolymer having amino group as adhesive | TOYODA GOSEI CO., LTD. (JP) | 1991-09-10 | — | — | US | claimed |
| US-4877687-A | SURFACE TREATMENT WITH A QUATERNIZED ACRYLATED RESIN | MITSUBISHI RAYON COMPANY, LTD. (JP) | 1989-10-31 | — | — | US | claimed |
| US-4751277-A | OIL-RESISTANT RUBBER | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1988-06-14 | — | — | US | claimed |
| US-4091165-A | COATING OF A POLYMER OF AMINOALKYL ACRYLATE, ALKYL ACRYLATE AND VINYL MONOMER TREATED WITH HALOACETIC ACID SALT | MITSUBISHI PETROCHEMICAL CO., LTD. (JA) | 1978-05-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717471-B2 | Hydrogel microcapsules | MITF, DSG1, SHH | TSHR 2621/4885MMP1 68/4885MMP2 809/4885 |
| US-20230025280-A1 | PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR | HRAS, CA13, CA12 | TSHR 2310/4885MMP1 421/4885MMP2 1677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.